Poor Phorm (PHRM) …it will have run out of cash within six weeks and so unless it can get away yet another fund raise it will be toast by Easter. But before we look forward to that, I have a number of questions for AIM Cessoit listed Phorm and its former Nomad Liberum about events back in 2012.
On 1st June 2012 Phorm announced that it had managed to persuade an investor to buy 20% of it’s (yet to start up) Chinese subsidiary for £20 million. The implication was that Phorm’s retained stake was worth £80 million and as a read through its operations outside China would be worth an awful lot.
The statement reads.